Vlad Gendelman
Orthopaedic Surgery · North Hollywood, CANPI 1336339738
Payments from drug & device makers
Across 37 payments — averaging $143.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lima USA, Inc.$2K
- Medacta USA, Inc.$2K
- Linvatec Corporation$285
- Stryker$162
- Anika Therapeutics, Inc.$154
- Encore Medical, LP$128
- plus $397 from 6 others
What the payments were for
- Travel & lodging$2,97856%
- Food & beverage$2,34344%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lima USA, Inc. | 6 | $2,306 |
| Medacta USA, Inc. | 16 | $1,890 |
| Linvatec Corporation | 2 | $285 |
| Stryker | 3 | $162 |
| Anika Therapeutics, Inc. | 1 | $154 |
| Encore Medical, LP | 1 | $128 |
| UOC USA Inc | 1 | $122 |
| Vertex | 1 | $118 |
| Orthalign Inc | 2 | $54 |
| Bioventus LLC | 2 | $44 |
| Baxter Healthcare | 1 | $32 |
| ERMI LLC | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SMR Shoulder$2,140
- AMISTEM$1,275
- GMK SPHERE$638
- PRIMARY SHOULDER$282
- HYALOFAST$154
- AUGMENT$148
- LINVATEC ARTHROSCOPY$146
- LINVATEC SHOULDER ARTHROSCOPY$139
- DJO SURGICAL$128
- U2 and USTAR II$122
- JOURNAVX$118
- Delta Cup$108
- LANTERN SURGICAL ASSISTANT$108
How this compares
$5,322 in reported general payments places this provider in the 60th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 26 | $22,253 |
| Meloxicam | 487 | $842 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $220 |
| Gabapentin | 20 | $179 |
| Celecoxib | 35 | $141 |
| Tramadol Hcl | 14 | $12 |
| Ropinirole Hcl | 12 | $1 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in North Hollywood
- Bradford HackArcadia$18.3M
- Robert GorabOrange$14.5M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Peter NewtonSan Diego$7M
- Nirav AminPlacentia$5.8M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.